Literature DB >> 23031804

Psychometric properties of the Treatment-Emergent Activation and Suicidality Assessment Profile (TEASAP) in youth with OCD.

Regina Bussing1, Tanya K Murphy, Eric A Storch, Joseph P H McNamara, Adam M Reid, Cynthia W Garvan, Wayne K Goodman.   

Abstract

This study evaluated the psychometric properties of the treatment-emergent activation and suicidality assessment profile (TEASAP) in a clinical sample of 56 youth aged 7-17 with obsessive-compulsive disorder (OCD) who participated in a double-blind randomized controlled trial. The 38-item TEASAP demonstrated good internal consistency for its total score (α=0.93) and adequate to good performance for its five subscale scores (α=0.65-0.92). One-week test-retest stability (N=18) was adequate (Intraclass correlation coefficient [ICC]=0.68-0.80) except for Self-Injury (ICC=0.46). Construct validity was supported by total and subscale TEASAP score relationships with related constructs, including irritability, hyperactivity, externalizing behaviors, manic symptoms, and suicidal ideation, and the absence of relationships with unrelated constructs. Predictive validity was established for the Disinhibition subscale through significant associations with subsequent activation events. Furthermore, TEASAP sensitivity to change in activation scores over time was supported by longitudinal associations of TEASAP scores with clinician ratings of activation over the course of treatment. Findings indicate that the TEASAP has acceptable psychometric properties in a clinical sample of youth with OCD and merits further study in larger samples for additional refinement of its measurement approaches.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23031804      PMCID: PMC3540123          DOI: 10.1016/j.psychres.2012.09.019

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  39 in total

1.  The Aberrant Behavior Checklist with children and adolescents with dual diagnosis.

Authors:  J Rojahn; W J Helsel
Journal:  J Autism Dev Disord       Date:  1991-03

2.  Discriminative validity of a parent version of the Young Mania Rating Scale.

Authors:  Barbara L Gracious; Eric A Youngstrom; Robert L Findling; Joseph R Calabrese
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-11       Impact factor: 8.829

Review 3.  Nontricyclic antidepressants: current trends in children and adolescents.

Authors:  G J Emslie; J T Walkup; S R Pliszka; M Ernst
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-05       Impact factor: 8.829

4.  Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale.

Authors:  Eric A Storch; Tanya K Murphy; Gary R Geffken; Ohel Soto; Muhammad Sajid; Pam Allen; Jonathan W Roberti; Erin M Killiany; Wayne K Goodman
Journal:  Psychiatry Res       Date:  2004-11-30       Impact factor: 3.222

Review 5.  Antidepressant-induced jitteriness/anxiety syndrome: systematic review.

Authors:  Lindsey I Sinclair; David M Christmas; Sean D Hood; John P Potokar; Andrea Robertson; Andrew Isaac; Shrikant Srivastava; David J Nutt; Simon J C Davies
Journal:  Br J Psychiatry       Date:  2009-06       Impact factor: 9.319

6.  The psychometric properties of the MASC in a pediatric psychiatric sample.

Authors:  Moira A Rynn; Jacques P Barber; Sarosh Khalid-Khan; Lynne Siqueland; Michelle Dembiski; Kevin S McCarthy; Robert Gallop
Journal:  J Anxiety Disord       Date:  2006

7.  Antidepressant side effects in children and adolescents.

Authors:  C Thomas Gualtieri; Lyn G Johnson
Journal:  J Child Adolesc Psychopharmacol       Date:  2006 Feb-Apr       Impact factor: 2.576

8.  The Clinical Utility of the Behavior Rating Inventory of Executive Function (BRIEF) in the diagnosis of ADHD.

Authors:  Stephen McCandless; Liz O' Laughlin
Journal:  J Atten Disord       Date:  2007-05       Impact factor: 3.256

9.  Factor structure of the Child Behavior Checklist/6-18 in a sample of girls adopted from China.

Authors:  Robert F Dedrick; Tony Xing Tan; Kofi Marfo
Journal:  Psychol Assess       Date:  2008-03

10.  Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.

Authors:  Jason Gallant; Eric A Storch; Lisa J Merlo; Emily D Ricketts; Gary R Geffken; Wayne K Goodman; Tanya K Murphy
Journal:  J Anxiety Disord       Date:  2008-02-07
View more
  9 in total

1.  Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial.

Authors:  Adam M Reid; Joseph P H McNamara; Tanya K Murphy; Andrew G Guzick; Eric A Storch; Wayne K Goodman; Gary R Geffken; Regina Bussing
Journal:  J Psychiatr Res       Date:  2015-10-14       Impact factor: 4.791

2.  Peer social interaction is facilitated in juvenile rhesus monkeys treated with fluoxetine.

Authors:  Mari S Golub; Casey E Hogrefe; Alicia M Bulleri
Journal:  Neuropharmacology       Date:  2016-02-22       Impact factor: 5.250

3.  A pilot study of actigraphy as an objective measure of SSRI activation symptoms: results from a randomized placebo controlled psychopharmacological treatment study.

Authors:  Regina Bussing; Adam M Reid; Joseph P H McNamara; Johanna M Meyer; Andrew G Guzick; Dana M Mason; Eric A Storch; Tanya K Murphy
Journal:  Psychiatry Res       Date:  2014-12-10       Impact factor: 3.222

Review 4.  Antidepressant-Induced Activation in Children and Adolescents: Risk, Recognition and Management.

Authors:  Marissa J Luft; Martine Lamy; Melissa P DelBello; Robert K McNamara; Jeffrey R Strawn
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2018-01-19

5.  A Double-Blind Randomized Trial to Investigate Mechanisms of Antidepressant-Related Dysfunctional Arousal in Depressed or Anxious Youth at Familial Risk for Bipolar Disorder.

Authors:  Duncan C Honeycutt; Melissa P DelBello; Jeffrey R Strawn; Laura B Ramsey; Luis R Patino; Kyle Hinman; Jeffrey Welge; David J Miklowitz; Booil Jo; Thomas J Blom; Kaitlyn M Bruns; Sarah K Hamill Skoch; Nicole Starace; Maxwell J Tallman; Manpreet K Singh
Journal:  J Pers Med       Date:  2022-06-20

6.  Attention-deficit hyperactivity disorder in elementary school students in Shantou, China: prevalence, subtypes, and influencing factors.

Authors:  Yanhong Huang; Shaoxiong Zheng; Chongtao Xu; Kun Lin; Kusheng Wu; Maochun Zheng; Jie Zhang; Haiyun Xu
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-14       Impact factor: 2.570

7.  Commentary: Duty to Warn: Antidepressant Black Box Suicidality Warning is Empirically Justified.

Authors:  Wayne K Goodman; Eric A Storch
Journal:  Front Psychiatry       Date:  2020-04-30       Impact factor: 4.157

8.  Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders.

Authors:  Stacey L Aldrich; Ethan A Poweleit; Cynthia A Prows; Lisa J Martin; Jeffrey R Strawn; Laura B Ramsey
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810

9.  Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial.

Authors:  Jeffrey R Strawn; Ethan A Poweleit; Jeffrey A Mills; Heidi K Schroeder; Zoe A Neptune; Ashley M Specht; Jenni E Farrow; Xue Zhang; Lisa J Martin; Laura B Ramsey
Journal:  J Pers Med       Date:  2021-11-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.